bioAffinity Technologies, Inc. (BIAF)
9.82
-0.68
(-6.48%)
USD |
NASDAQ |
Sep 10, 12:27
bioAffinity Technologies Market Cap : 4.441M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 4.748M |
| September 08, 2026 | 4.038M |
| September 04, 2026 | 6.905M |
| September 03, 2026 | 5.779M |
| September 02, 2026 | 4.409M |
| September 01, 2026 | 2.98M |
| August 31, 2026 | 2.062M |
| August 28, 2026 | 2.202M |
| August 27, 2026 | 2.288M |
| August 26, 2026 | 2.302M |
| August 25, 2026 | 2.347M |
| August 24, 2026 | 2.632M |
| August 21, 2026 | 2.713M |
| August 20, 2026 | 2.714M |
| August 19, 2026 | 2.774M |
| August 18, 2026 | 48.16M |
| August 17, 2026 | 39.88M |
| August 14, 2026 | 40.91M |
| August 13, 2026 | 38.97M |
| August 12, 2026 | 48.10M |
| August 11, 2026 | 49.45M |
| August 10, 2026 | 49.86M |
| August 07, 2026 | 51.89M |
| August 06, 2026 | 53.89M |
| August 05, 2026 | 53.90M |
| Date | Value |
|---|---|
| August 04, 2026 | 56.00M |
| August 03, 2026 | 60.78M |
| July 31, 2026 | 63.84M |
| July 30, 2026 | 65.57M |
| July 29, 2026 | 59.52M |
| July 28, 2026 | 63.94M |
| July 27, 2026 | 69.36M |
| July 24, 2026 | 67.14M |
| July 23, 2026 | 67.95M |
| July 22, 2026 | 72.03M |
| July 21, 2026 | 71.74M |
| July 20, 2026 | 71.11M |
| July 17, 2026 | 71.60M |
| July 16, 2026 | 72.42M |
| July 15, 2026 | 73.50M |
| July 14, 2026 | 72.18M |
| July 13, 2026 | 71.21M |
| July 10, 2026 | 78.00M |
| July 09, 2026 | 79.18M |
| July 08, 2026 | 80.28M |
| July 07, 2026 | 84.45M |
| July 06, 2026 | 82.23M |
| July 02, 2026 | 84.45M |
| July 01, 2026 | 85.82M |
| June 30, 2026 | 82.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 277.56M |
| Perspective Therapeutics, Inc. | 319.44M |
| MiMedx Group, Inc. | 659.40M |
| Veracyte, Inc. | 3.450B |
| ABVC BioPharma, Inc. | 25.77M |
Market Cap Related Metrics
| PS Ratio | 0.4239 |
| Price to Book Value | 1.178 |
| Price | 9.82 |
| Earnings Yield | -1.05K% |